NL-OMON54541招募中不适用
se of the NMF biomarker as predictive diagnostic for effective use of cyclosporine and dupilumab in the treatment of atopic dermatitis. - NMF-CsA-dupi trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 186
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •children and adolescents, aged between 2 - 18 years, with moderate to severe
- •atopic dermatitis
- •(AD diagnosed according to the UK working party criteria) - patient and
- •parents/guardians able to
- •participate in the study and willing to give written informed consent - EASI
- •(Eczema Area Severity
- •Index) >= 6 at screening and baseline (corresponding with moderate-to-severe
- •disease) - IGA
- •(Investigators Global Assessment) >= 3 at screening and baseline (corresponding
- •with moderate-to-severe
排除标准
- •children under the age of 2 years (due to the prescribe conditions of CsA) and
- •patients older
- •than 18 years - contraindication for CsA - contraindication for dupilumab -
- •patient (or one of the
- •parents/guardians) not willing to be randomized - children with a history of
- •any known primary
- •immunodeficiency disorder - children with a history of cancer - EASI < 6 at
- •screening or at baseline -
- •IGA - Pregnancy
研究者
相似试验
进行中（未招募）
1 期
MF biomarker as predictive diagnostic for effective use of ciclosporine in atopic dermatitis.Atopic dermatitisEUCTR2019-003247-30-NLErasmus MC152
尚未招募
不适用
se of the NMF Biomarker as Predictive Diagnostic for Effective Use of Cyclosporine and Dupilumab in the Treatment of Atopic DermatitisAtopic dermatitisNL-OMON23450Erasmus MC318
招募中
不适用
Identification of biomarkers for prognosis of morbidity and mortality of SARS-CoV-2 (COVID-19) patientsJ12.8Other viral pneumoniaDRKS00023322niversitätsklinikum Münster250
已完成
不适用
Elucidation of biomarkers to predict the presence of coronary vulnerable plaqueJPRN-UMIN000009806agasaki University Graduate School of Biomedical Sciences200
已完成
不适用
Prospective study for predictive biomarkers and modified risk scoring model for venous thromboembolism in Japanese patients with unresectable or metastatic cancer.lung cancer, esophageal cancer, gastric cancer, biliary tract cancer, pancreatic cancer, colorectal cancerJPRN-UMIN000026826Clinical Research Center, Saga University Hospital240